Salisbury Medical Solutions Limited - Accounts to registrar (filleted)

REGISTERED NUMBER: 10674988 (England and Wales)

Unaudited Financial Statements for the Year Ended 31 March 2025

for

Salisbury Medical Solutions Limited

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

DIRECTORS:

Mr N Jacobs

Dr P V Jacobs

REGISTERED OFFICE:

Solent House

107a Alma Road

Portswood

Southampton

Hampshire

SO14 6UY

REGISTERED NUMBER:

10674988 (England and Wales)

ACCOUNTANTS:

Thomas Croft Limited

Accountants And Taxation Consultants

Solent House

107a Alma Road

Portswood

Southampton

Hampshire

SO14 6UY

FIXED ASSETS

Tangible assets

4

23,782

31,806

Investments

5

101,639

98,682

125,421

130,488

CURRENT ASSETS

Debtors

6

28,846

26,352

Cash at bank

255,493

196,011

284,339

222,363

CREDITORS

Amounts falling due within one year

7

22,227

24,420

NET CURRENT ASSETS

262,112

197,943

TOTAL ASSETS LESS CURRENT
LIABILITIES

387,533

328,431

CAPITAL AND RESERVES

Called up share capital

8

100

Retained earnings

387,433

328,331

SHAREHOLDERS' FUNDS

387,533

328,431

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 23 December 2025 and were signed on its behalf by:

Mr N Jacobs - Director

1.	STATUTORY INFORMATION

Salisbury Medical Solutions Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill

Goodwill, being the amount paid in connection with the acquisition of a business has been fully amortised in the current year.

Intangible assets

Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Fixtures and fittings

-

25% on reducing balance

Motor vehicles

-

25% on reducing balance

Computer equipment

-

33% on cost

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2024 - NIL).

4.	TANGIBLE FIXED ASSETS

Fixtures

and

Motor

Computer

fittings

vehicles

equipment

Totals

£

COST

At 1 April 2024

1,500

49,865

5,022

56,387

Additions

-

824

At 31 March 2025

1,500

49,865

5,846

57,211

DEPRECIATION

At 1 April 2024

733

21,816

2,032

24,581

Charge for year

192

7,012

1,644

8,848

At 31 March 2025

925

28,828

3,676

33,429

NET BOOK VALUE

At 31 March 2025

575

21,037

2,170

23,782

At 31 March 2024

767

28,049

2,990

31,806

5.	FIXED ASSET INVESTMENTS

Other

investments

£

COST OR VALUATION

At 1 April 2024

98,682

Additions

2,210

Revaluations

747

At 31 March 2025

101,639

NET BOOK VALUE

At 31 March 2025

101,639

At 31 March 2024

98,682

Cost or valuation at 31 March 2025 is represented by:

Other

investments

£

Valuation in 2022

96,836

Valuation in 2023

(7,256

)

Valuation in 2024

9,102

Valuation in 2025

2,957

101,639

6.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.3.25

31.3.24

£

Trade debtors

16,704

17,596

Other debtors

2,533

-

Prepayments

9,609

8,756

28,846

26,352

7.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.3.25

31.3.24

£

Trade creditors

1,013

1,298

Corporation tax

18,120

16,393

Social security and other taxes

136

Other creditors

-

478

Directors' current accounts

1,697

4,901

Accrued expenses

1,261

1,214

22,227

24,420

8.	CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:

Number:

Class:

Nominal

31.3.25

31.3.24

value:

£

100

Ordinary

£1

100

9.	DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 31 March 2025 and 31 March 2024:

31.3.25

31.3.24

£

Mr N Jacobs

Balance outstanding at start of year

(2,990

)

(1,467

)

Amounts advanced

3,019

723

Amounts repaid

(1,417

)

(2,246

)

Amounts written off

-

Amounts waived

-

Balance outstanding at end of year

(1,388

)

(2,990

)

Dr P V Jacobs

Balance outstanding at start of year

(1,910

)

(1,467

)

Amounts advanced

3,019

723

Amounts repaid

(1,417

)

(1,166

)

Amounts written off

-

Amounts waived

-

Balance outstanding at end of year

(308

)

(1,910

)

10.	RELATED PARTY DISCLOSURES

During the year, total dividends of £1,000 were paid to the directors .

The company was under the control of Mr N & Mrs P V Jacobs throughout the current and previous year. Mr N Jacobs is the managing director and majority shareholder.

No transactions with related parties were undertaken such as are required to be disclosed under Section 1a (Small Entities) for Financial Reporting Standard 102.

The company is a member of Orthopaedics Plastics & Spinal Specialists LLP (OC380828) and received £4,111 during the year. The Investment in Orthopaedics Plastics & Spinal Specialists LLP is carred on the balance sheet in other debtors at £2,533.